Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for Secondary Prevention of Spontaneous Bacterial Peritonitis
NCT04746937Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of nitazoxanide in spontaneous bacterial peritonitis (SBP), sponsored by Tanta University. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT04746937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04746937.